文献速递乳房整形与再造显微修复重建

神经同种异体移植用于植入物乳房再造中乳房神经化的安全性:全国倾向性评分匹配分析

Safety of Breast Neurotization Using Nerve Allografts in Implant-Based Breast Reconstruction: A Nationwide Propensity-Score-Matched Analysis.
PubMed 文献 · Ann Plast Surg · 2026-05-21

本研究基于TriNetX回顾性队列,纳入2006至2026年接受乳房切除并即刻植入物乳房再造的女性患者35173例,其中759例同期行神经同种异体移植神经化。经1:1倾向性评分匹配后,神经移植组与对照组各759例,术后6个月、1年及3年主要并发症发生率均无显著差异。结论认为该技术未增加术后并发症,支持在合适患者中应用。

要点

  • 神经同种异体移植神经化未增加植入物乳房再造术后主要并发症。
  • 匹配后两组各759例,6个月、1年及3年主要并发症率均无显著差异。
  • 结果为在合适患者中开展感觉恢复技术提供了安全性支持。

核心结论

  • 在迄今最大规模对比分析中,植入物乳房再造时使用神经同种异体移植行乳房神经化未增加术后并发症。
  • 研究结果支持在合适选择的患者中将感觉恢复技术纳入植入物乳房再造。

研究设计与样本

  • 回顾性队列研究,使用TriNetX研究网络数据。
  • 纳入2006至2026年接受乳房切除并即刻植入物乳房再造的18岁及以上女性患者。
  • 按再造时是否使用神经同种异体移植行神经吻合分层,并进行1:1倾向性评分匹配,匹配变量包括人口学、体重指数、合并症、化疗史和放疗史。
  • 共识别35173例患者,其中759例接受乳房神经化;匹配后每组各759例,基线特征均衡。

主要发现

  • 在6个月、1年及3年随访时,神经移植组与对照组主要并发症发生率均无显著差异。
  • 主要并发症包括手术部位并发症、感染、伤口裂开、假体取出、包膜挛缩以及急诊就诊或再入院。

临床怎么用

  • 在合适选择的患者中,植入物乳房再造同期行神经同种异体移植神经化可考虑用于感觉恢复,未观察到并发症增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast neurotization has been proposed as a strategy to restore sensation following implant-based breast reconstruction. Although early studies demonstrate promising sensory outcomes, the safety of nerve grafting in this setting has not been evaluated at scale. This study examines whether breast neurotization using nerve allografts is associated with increased postoperative complications following implant-based breast reconstruction. METHODS: A retrospective cohort study was performed using the TriNetX Research Network. Female patients aged 18 years and older undergoing mastectomy with immediate implant-based breast reconstruction between 2006 and 2026 were identified. Patients were stratified into cohorts based on the presence or absence of neurorrhaphy using nerve allografts at the time of reconstruction. Propensity score matching (1:1) was performed using demographics, body mass index, comorbidities, chemotherapy history, and radiation therapy history. Postoperative complications were analyzed at 6 months, 1 year, and 3 years. Major complications included surgical site complications, infection, wound disruption, explantation, capsular contracture, and return to the emergency department or hospital readmission. RESULTS: A total of 35,173 patients were identified, including 759 patients who underwent breast neurotization. After 1:1 matching, 759 patients remained in each cohort with balanced baseline characteristics. No significant differences in rates of major complications were observed between the nerve graft and control cohorts at any time point. CONCLUSIONS: In the largest comparative analysis to date, breast neurotization using nerve allografts during implant-based reconstruction was not associated with increased postoperative morbidity. These findings support the safety of incorporating sensory restoration techniques into implant-based breast reconstruction in appropriately selected patients.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Chaudhry AS, Rabin DA, Kelley E, et al. Safety of Breast Neurotization Using Nerve Allografts in Implant-Based Breast Reconstruction: A Nationwide Propensity-Score-Matched Analysis. Ann Plast Surg. 2026. PMID: 42165636. doi:10.1097/SAP.0000000000004779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。